I was out for a while, but bought back for a small position last week. I intend to build a position over time. The company is worth a lot more than the market currently recognizes. The new us patient of Anatabine Cirate to be used as an anti-inflammatory is very valuable,imo.
The science is terrific and will prove to be so over time. Maybe we will have the results from the 1B clinical by this fall or winter. Positive results should bring RCPI a JV partner.